More and more evidence that germline risk for certain conditions in non-cancer patients elevates the risk of related conditions in cancer patients (e.g. adverse events) and could be helpful in monitoring.

Want to learn more about prediction of immune checkpoint inhibitor cessation due to toxicities then stop by our poster on April 8th, 1:30PM-5:00PM (Poster no. 3460) #AACR24 Rohit Thummalapalli Elad Ziv Adam J. Schoenfeld Dr. Melinda Aldrich, MPH, PhD Christine Lovly, MD, PhD, FASCO

Our new paper Nature Medicine is out: tinyurl.com/4ckhwcc9 We measured glucose levels continuously in 8,315 people and show high intrapersonal variability in morning fasting glucose (FG) levels We find that for 5,328 individuals who would have been considered to have normal

It pains me to see facile critiques of GWAS on here from our clinical/biostats friends while the many actually good reasons to be critical of GWAS get little attention. So here's a thread on what GWAS does, what critics get wrong, and where GWAS is genuinely still lacking. 🧵:

So excited to share this paper with everyone! This described our UCSF PROPEL program, which began in 2020 with just a few scholars, but has already grown to nearly 200 cumulative scholars over the last few years! Let's gooooo!!!!

Delighted to present our work on polygenic scores of blood cell profiles and gastrointestinal toxicities in immune checkpoint inhibitor patients at IGES 2024 (Session 7, Nov 4) #IGES24 Elad Ziv @Linda_Kachuri

Interested in learning about genetic prediction of hepatoxicity in cancer patients treated with immune checkpoint inhibitor, come stop by my poster (# 7016) on Nov 8th #ASHG24 Elad Ziv Dr. Melinda Aldrich, MPH, PhD

Currently presenting her award winning poster at #ASHG2024

The newest Regeneron Genetics Center method, REMETA, from Tyler Joseph, Jonathan Marchini, and co. is a game changer - enabling the ability to reconstruct gene-based test associations from single variant summary statistics (and LD).

Dear early career genetic epidemiologists: The IGES Young Investigator Committee is looking for new members! It's a fun group, low time commitment, and a great way to network with peers while supporting trainees around the world. Apply here by Dec 31st: geneticepi.org/yic_position-o…

If you are an early career researcher looking for opportunities to serve on a professional committee in the field of genetic epidemiology, open positions for IGES committees are available. More info on committees & application process: geneticepi.org/yic_position-o… IGES

Excited to share our latest work exploring the role of germline genetics in the development of multiple primary cancers @Linda_Kachuri Jovia Nierenberg Taylor Cavazos Elad Ziv lori sakoda @johnwitte

Excited to share our new manuscript on evaluating multi-ancestry GWAS methods using large-scale simulations & real data from UK Biobank (N≈324K) & All of Us (N≈207K)! My first thesis paper under the guidance of Pete Kraft & Haoyu Zhang. Available at: medrxiv.org/content/10.110…

**New Paper** comparing MASALA to Indian LASI-DAD and the U.S. HRS after adjusting for immigration selection factors 1. Highest DM prevalence in India 2. More acculturated Indians in MASALA had lower diabetes prevalence USC UCLA UC San Francisco sciencedirect.com/science/articl…